DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Scheen AJ.
SGLT2 Inhibitors: Benefits/Risk Balance.
Curr Diab Rep 2016;
16: 92
We do not assume any responsibility for the contents of the web pages of other providers.